PINGTUNG COUNTY, Taiwan

Rong-Lin Zhang

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Rong-Lin Zhang

Introduction

Rong-Lin Zhang is a notable inventor based in Pingtung County, Taiwan. He has made significant contributions to the field of medical technology, particularly in the treatment of brain cancers. His innovative approach utilizes advanced materials to enhance the efficacy of chemotherapy.

Latest Patents

One of Rong-Lin Zhang's key patents is titled "Drug-loaded mesoporous silica nanoparticle for prevention and treatment of brain cancers or brain metastases." This patent describes a method for preventing or treating brain cancers using mesoporous silica nanoparticles (MSNs) that are loaded with taxane-based chemotherapeutic drugs, specifically paclitaxel (PTX), cabazitaxel (CTX), or docetaxel (DTX). This innovative method aims to improve the delivery and effectiveness of cancer treatment.

Career Highlights

Throughout his career, Rong-Lin Zhang has worked with various companies that focus on biopharmaceuticals and drug development. Notably, he has been associated with Nano Targeting & Therapy Biopharma Inc. and Scinopharm Taiwan, Ltd. His work in these organizations has contributed to advancements in targeted therapies for cancer treatment.

Collaborations

Rong-Lin Zhang has collaborated with several professionals in his field, including Cheng-Hsun Wu and Si-Han Wu. These collaborations have fostered a productive environment for innovation and research in cancer therapies.

Conclusion

Rong-Lin Zhang's contributions to the field of medical technology, particularly in the treatment of brain cancers, highlight his innovative spirit and dedication to improving patient outcomes. His work continues to inspire advancements in cancer treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…